Christine Durier

1.1k citations

31 papers · 776 indexed · h-index 16

Co-authors: J Aboulker Odile Launay Jean‐François Delfraissy Yves Lévy Cécile Goujard Alain Baron Jean‐Gérard Guillet Christine Rouzioux
Topics: HIV Research and Treatment (19 papers)HIV/AIDS Research and Interventions (8 papers)HIV/AIDS drug development and treatment (5 papers)
Cited by: Virology Biotechnology Infectious Diseases
Journals: Nature Medicine PLoS ONE Clinical Infectious Diseases
Partner nations: France United States Netherlands

In The Last Decade

Christine Durier

31 papers receiving 761 citations

Peers

Countries citing papers authored by Christine Durier

Since Specialization

Citations

This map shows the geographic impact of Christine Durier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Durier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Durier more than expected).

Fields of papers citing papers by Christine Durier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Durier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Durier. The network helps show where Christine Durier may publish in the future.

Co-authorship network of co-authors of Christine Durier

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Durier. A scholar is included among the top collaborators of Christine Durier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Durier. Christine Durier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A prospective national cohort evaluating ring MVA vaccination as post-exposure prophylaxis for monkeypox 2022 ·Nature Medicine ·Liêm Binh Luong Nguyen,Jade Ghosn,Christine Durier,(unknown),Éric Tartour,(unknown),Tabassome Simon,Brigitte Autran,Inmaculada Ortega‐Pérez,(unknown),Jeremy K. Ward,(unknown),Laurence Meyer,Alexandra Rousseau,Laurence Bérard,Xavier de Lamballerie,Odile Launay	16
2	Hepatitis B e Antigen (HBeAg) Rapid Test and Alanine Aminotransferase Level–Based Algorithm to Identify Pregnant Women at Risk of HBV Mother-to-Child Transmission: The ANRS 12345 TA PROHM Study 2020 ·Clinical Infectious Diseases ·Olivier Ségéral,Bunnet Dim,Christine Durier,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Janin Nouhin,(unknown),Laurence Borand	10
3	Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials 2019 ·AIDS ·Christine Durier,Corinne Desaint,Jean‐Daniel Lelièvre,Benjamin Silbermann,Gilles Pialoux,Lise Cuzin,(unknown),Isabelle Poizot‐Martin,(unknown),Christelle Paul,Sophie Grabar,Bruno Spire,Laurence Meyer,Odile Launay	5
4	Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients 2018 ·AIDS ·Nathalie Verdière,Christine Durier,Assia Samri,Vincent Meiffrédy,Odile Launay,Sophie Matheron,Séverine Mercier‐Delarue,(unknown),J Aboulker,Jean‐Michel Molina,Brigitte Autran,François Simon	18
5	Motivational interviewing training for medical students: A pilot pre-post feasibility study 2018 ·Patient Education and Counseling ·Antoine Chéret,Christine Durier,Nicolas Noël,Katia Bourdic,Chantal Legrand,(unknown),(unknown),Cécile Goujard,(unknown),Silla M. Consoli	11
6	Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial 2017 ·Vaccine ·Sodiomon B. Sirima,Christine Durier,(unknown),Sophie Houard,Adama Gansané,Pierre Loulergue,Mathilde Bahuaud,Nadine Benhamouda,Issa Nébié,Bart W. Faber,Edmond J. Remarque,Odile Launay,Espérance Ouédraogo,Guillaume Sanou,Sonia Guéguen,(unknown),(unknown),Clemens H. M. Kocken,Frédéric Batteux,Éric Tartour	30
7	Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype 2017 ·PLoS ONE ·Séverine Mercier‐Delarue,Christine Durier,Nathalie Verdière,Jean‐Dominique Poveda,Vincent Meiffrédy,María Dolores Fernández-García,Stéphane Lastère,Raymond Césaire,(unknown),Jean‐Michel Molina,Ali Amara,François Simon	14
8	Update of the Long-term Follow-up of Healthy Volunteers from Preventive HIV-1 Vaccine Trials: ANRS COV1-COHVAC Cohort 2014 ·AIDS Research and Human Retroviruses ·Corinne Desaint,Christine Durier,Jean‐Daniel Lelièvre,Benjamin Silbermann,Gilles Pialoux,Lise Cuzin,Isabelle Poizot‐Martin,P Morineau,(unknown),Bruno Spire,Yves Lévy,J Aboulker,Odile Launay	1
9	Long-term CD4+ and CD8+ T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16) 2013 ·Vaccine ·Odile Launay,Mathieu Surénaud,Corinne Desaint,Nadine Benhamouda,Gilles Pialoux,(unknown),Isabelle Poizot‐Martin,Gustavo F. Gonzáles,Lise Cuzin,Isabelle Bourgault‐Villada,Yves Lévy,Jeannine Choppin,Christine Durier	13
10	Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers 2013 ·AIDS ·Laura Richert,Sophie Hüe,Hakim Hocini,(unknown),Christine Lacabaratz,Mathieu Surénaud,Aurélie Wiedemann,Pascaline Tisserand,Christine Durier,Dominique Salmon,Jean‐Daniel Lelièvre,Geneviève Chêne,Rodolphe Thiébaut,Yves Lévy	16
11	Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03A adjuvant in HIV-1-infected adults 2012 ·AIDS ·Christine Durier,Corinne Desaint,F. Lucht,Pierre‐Marie Girard,Yves Lévy,Thierry May,C. Michelet,Agathe Rami,François Roman,Jean‐François Delfraissy,J Aboulker,Odile Launay	20
12	Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial 2011 ·The Journal of Infectious Diseases ·Odile Launay,Corinne Desaint,Christine Durier,Pierre Loulergue,Xavier Duval,Christine Jacomet,Gilles Pialoux,Jade Ghosn,F. Raffi,David Rey,Faïza Ajana,Nathalie Verdière,Jacques Reynes,Valérie Foubert,François Roman,Jeanne‐Marie Devaster,Jean‐François Delfraissy,J Aboulker	43
13	IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort 2010 ·Journal of Antimicrobial Chemotherapy ·Éric Fontas,Isabelle Kousignian,Christian Pradier,(unknown),Christine Durier,Laurence Weiss,Yves Lévy,Dominique Costagliola,(unknown),(unknown)	4
14	Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial 2010 ·AIDS ·Dominique Salmon‐Céron,Christine Durier,Corinne Desaint,Lise Cuzin,Mathieu Surénaud,Nadine Benhamouda,Jean‐Daniel Lelièvre,(unknown),Gilles Pialoux,Isabelle Poizot‐Martin,J Aboulker,Yves Lévy,Odile Launay	39
15	Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals 2006 ·AIDS ·Yves Lévy,Christine Durier,Anne‐Sophie Lascaux,Vincent Meiffrédy,Hanne Gahéry‐Ségard,Cécile Goujard,Christine Rouzioux,(unknown),Jean‐Gérard Guillet,Michel D. Kazatchkine,Jean‐François Delfraissy,J Aboulker	65
16	Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults 2006 ·AIDS ·Christine Durier,Odile Launay,Vincent Meiffrédy,Yacine Saïdi,Dominique Salmon,Yves Lévy,Jean‐Gérard Guillet,Gilles Pialoux,J Aboulker	49
17	Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection 2003 ·AIDS ·Yves Lévy,Christine Durier,Roman Krzysiek,Claire Rabian,Catherine Capitant,Anne‐Sophie Lascaux,Christophe Michon,Éric Oksenhendler,Laurence Weiss,Jean‐Albert Gastaut,Cécile Goujard,Christine Rouzioux,J Maral,Jean‐François Delfraissy,Dominique Émilie,J Aboulker	82
18	On the Use of Magnitude of Reduction in HIV-1 RNA in Clinical Trials: Statistical Analysis and Potential Biases 2002 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Philippe Flandre,Christine Durier,Diane Descamps,Odile Launay,Véronique Joly	15
19	Assessment of the virulence of Listeria monocytogenes: agreement between a plaque-forming assay with HT-29 cells and infection of immunocompetent mice 2001 ·International Journal of Food Microbiology ·Sylvie Roche,Philippe Velge,Elisabeth Bottreau,Christine Durier,N. Marquet-Van Der Mee,Pierre Pardon	88
20	Somatotropin Treatment Does Not Affect Nonesterified Fatty Acid Response to Adrenergic Injections in Underfed or Overfed Nonlactating Cows 1996 ·Journal of Nutrition ·Anne Ferlay,Yves Chilliard,(unknown),Christine Durier,François Bocquier	10

About Christine Durier

Christine Durier is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 31 papers that have together received 776 indexed citations. Recurring topics across this work include HIV Research and Treatment (19 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Virology (368 citations), Biotechnology (132 citations) and Infectious Diseases (223 citations). Christine Durier has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include J Aboulker, Odile Launay, Jean‐François Delfraissy, Yves Lévy, Cécile Goujard, Alain Baron, Jean‐Gérard Guillet, Christine Rouzioux, Pierre Pardon and Sylvie Roche. Their work appears in journals such as Nature Medicine, PLoS ONE and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact